Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.
about
Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cellsMolecular integrative clustering of Asian gastric cell lines revealed two distinct chemosensitivity clustersSuperior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myelomaProteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedsideProteasome inhibitors in mantle cell lymphomaDual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma.Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancerObatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivoBortezomib for the treatment of non-Hodgkin's lymphomaHistone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer.Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer.Targeting Waldenstrom macroglobulinemia with histone deacetylase inhibitors.Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma.Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions.HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2.Enhancing proteotoxic stress as an anticancer strategy.Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl)methanone through upregulating hTERT induces cell apoptosis and ERS.(S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1.Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and PromisesOncolytic Viruses for Multiple Myeloma Therapy.
P2860
Q24298561-7C12DB3F-6405-471B-8327-9E9F81921BF7Q28544116-5BC4632F-C0B8-4B7C-8B41-9B1AAADD4322Q33959993-A02D2C58-A675-42B8-BCD6-231D6B00AEE5Q33983255-A7687DFC-AAB3-4E3F-AA98-4FB3BADBE4F1Q34127846-9AA624C0-15D6-4A5D-B66E-553A136171D6Q34231446-CEB34A98-A35D-4DCF-AB0A-9220668E20D2Q35915726-775AEB82-BF72-443C-9AA1-EE038A173150Q35989980-AEFDA892-DAA0-4373-895E-9384E89C7983Q36028745-28D2572D-A737-441F-ABB6-777D42EE07C4Q36172596-75E44C8A-EFD1-4CEC-A110-357D6183B1FBQ36546701-029A335E-4F1F-4FF0-8B5F-3CC2D679DEA9Q36697045-180504D9-6934-4794-ABB6-3A2660ED7EFFQ36868056-E12C4459-E370-4C3C-BC3F-3BAECA4B664BQ36893027-D93C1E59-82AE-468B-941C-AF88B272CB3DQ37062074-F94BE014-8641-46F8-812D-122980670C77Q37306916-12DF5AEF-12CB-46B5-8AA5-6684163C9865Q37326878-5440A6C0-BD2E-4BED-ADE6-4C2D43112866Q37821337-06EF431E-2C0D-4DCE-A3FF-070895CD19B3Q38708291-7970E152-2CFE-4D85-A21F-315E3C94A79AQ39174431-687E3B32-1C11-46D3-BA30-BAF053086F5CQ39271550-F0DF2DF6-2572-421B-A8FE-81901F8F1A3FQ39631993-CF5F44D1-292F-4FE4-AFD6-05E0E6EC5C34Q40048494-ADD20DD8-AAAB-4FA4-AA10-5DF053E0FDE9Q41168816-4860FD3F-C7FD-4EBA-97C6-6AD542EB6885Q41523470-90039A61-85CA-46CB-8FD0-37737F377E5FQ41664067-6576E65A-196C-472F-9B31-8C7A25CDB84FQ55515625-DA13FE45-EB5E-4186-A50A-E0860B7B197F
P2860
Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@ast
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@en
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@nl
type
label
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@ast
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@en
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@nl
prefLabel
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@ast
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@en
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells.
@nl
P2093
P2860
P1476
Role of CAAT/enhancer binding ...... in mantle cell lymphoma cells
@en
P2093
Andrew Savoie
Eduardo Sotomayor
Jianguo Tao
Kapil N Bhalla
Kathleen M Buckley
Kyungsoo Ha
Peter Atadja
Ramesh Balusu
Srilatha Nalluri
P2860
P304
P356
10.1158/1078-0432.CCR-10-0529
P407
P50
P577
2010-07-20T00:00:00Z